Skip to main content
Veterinary Medicines

BASQUIN BCD

Authorised
  • Clostridium perfringens, type B, strain ATCC 3626, Inactivated
  • Clostridium perfringens, type C, strain ATCC 3628, Inactivated
  • Clostridium perfringens, type D, strain ATCC 3629, Inactivated
  • Clostridium perfringens, type B, strain ATCC 3626, type C, strain ATCC 3628 and type D, strain ATCC 3629, beta toxoid
  • Clostridium perfringens, type B, strain ATCC 3626, type C, strain ATCC 3628 and type D, strain ATCC 3629, epsilon toxoid

Product identification

Medicine name:
BASQUIN BCD
Active substance:
  • Clostridium perfringens, type B, strain ATCC 3626, Inactivated
  • Clostridium perfringens, type C, strain ATCC 3628, Inactivated
  • Clostridium perfringens, type D, strain ATCC 3629, Inactivated
  • Clostridium perfringens, type B, strain ATCC 3626, type C, strain ATCC 3628 and type D, strain ATCC 3629, beta toxoid
  • Clostridium perfringens, type B, strain ATCC 3626, type C, strain ATCC 3628 and type D, strain ATCC 3629, epsilon toxoid
Target species:
  • Sheep (lamb)
  • Goat (kid)
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Clostridium perfringens, type B, strain ATCC 3626, Inactivated
  • Clostridium perfringens, type C, strain ATCC 3628, Inactivated
  • Clostridium perfringens, type D, strain ATCC 3629, Inactivated
  • Clostridium perfringens, type B, strain ATCC 3626, type C, strain ATCC 3628 and type D, strain ATCC 3629, beta toxoid
    10.00
    Toxic unit(s)
    /
    2.00
    millilitre(s)
  • Clostridium perfringens, type B, strain ATCC 3626, type C, strain ATCC 3628 and type D, strain ATCC 3629, epsilon toxoid
    5.00
    Toxic unit(s)
    /
    2.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Sheep (lamb)
      • Meat and offal
        0
        day
    • Goat (kid)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI04AB01
Authorisation status:
  • Valid
Authorised in:
  • Spain
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • CZ Vaccines S.A.U.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Ovejero S.A.
Responsible authority:
  • Spanish Agency For Medicines And Health Products
Authorisation number:
  • 3348 ESP
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."